Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Noxopharm |
Description | Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company. The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy |
Keywords | Noxopharm, Veyonda |
WebSite | www.noxopharm.com |
Host IP | 54.79.107.72 |
Location | Sydney, New South Wales, Australia |
Site | Rank |
nyrada.com | #4,052,681 |
noxxon.com | #4,755,264 |
noxgroup.com | #587,714 |
nextbiotech.com.au | #2,752,366 |
noxmedical.com | #4,208,876 |
US$9,150
Last updated: Aug 6, 2020
Noxopharm.com has global traffic rank of 3,708,859. Noxopharm.com has an estimated worth of US$ 9,150, based on its estimated Ads revenue. Noxopharm.com receives approximately 835 unique visitors each day. Its web server is located in Sydney, New South Wales, Australia, with IP address 54.79.107.72. According to SiteAdvisor, noxopharm.com is safe to visit. |
Purchase/Sale Value | US$9,150 |
Daily Ads Revenue | US$5 |
Monthly Ads Revenue | US$150 |
Yearly Ads Revenue | US$1,830 |
Daily Unique Visitors | 835 |
Note: All traffic and earnings values are estimates. |
Global Rank | 3,708,859 |
Delta (90 Days) | 0 |
Most Popular In Country | N/A |
Country Rank | N/A |
Host | Type | TTL | Data |
noxopharm.com | A | 299 | IP: 54.79.107.72 |
noxopharm.com | MX | 299 | Priority: 0 Target: in.hes.trendmicro.com. |
noxopharm.com | MX | 299 | Priority: 50 Target: noxopharm-com.mail.protection.outlook.com. |
noxopharm.com | NS | 3599 | Target: ns3.netregistry.net. |
noxopharm.com | NS | 3599 | Target: ns2.netregistry.net. |
noxopharm.com | NS | 3599 | Target: ns1.netregistry.net. |
noxopharm.com | TXT | 3599 | TXT: MS=ms88149960 |
noxopharm.com | TXT | 3599 | TXT: hes=5edd4e26b6a5ffe3bbe1d106e6fec6ab |
noxopharm.com | TXT | 3599 | TXT: google-site-verification=uMUBR97DWOlkH00IWYhSUMfyfDrFxOSIqwDfbAgfLj4 |
noxopharm.com | TXT | 3599 | TXT: v=spf1 include:spf.hes.trendmicro.com include:spf.protection.outlook.com -all |
noxopharm.com | SOA | 3599 | MNAME: ns1.netregistry.net. RNAME: dmain.netregistry.net. Serial: 2020080402 Refresh: 86400 Retry: 7200 Expire: 3600000 Minimum TTL: 172800 |
HTTP/1.1 301 Moved Permanently Content-Type: text/html; charset=utf-8 Location: http://www.noxopharm.com/ Server: Microsoft-IIS/10.0 X-Powered-By: ASP.NET Date: Thu, 06 Aug 2020 12:43:14 GMT Content-Length: 142 HTTP/1.1 302 Found Cache-Control: private Cache-control: no-cache="set-cookie" Content-Type: text/html; charset=utf-8 Date: Thu, 06 Aug 2020 12:43:16 GMT Location: /site/content/ Server: Microsoft-IIS/10.0 Set-Cookie: AWSELB=6513754B1C5CC94C36D4FA97FE6911DC2DDBF7E46578628D015A9121F2184A1C3FF9BF0642C27E7A01616814D2D5248271BDE8AF0BEC647D418D1169CD37248CA537D3FA62;PATH=/;MAX-AGE=600 X-AspNet-Version: 4.0.30319 X-Powered-By: ASP.NET Content-Length: 131 Connection: keep-alive HTTP/1.1 302 Found Cache-control: no-cache="set-cookie" Content-Type: text/html; charset=utf-8 Date: Thu, 06 Aug 2020 12:43:15 GMT Location: https://www.noxopharm.com/site/content/ Server: Microsoft-IIS/10.0 Set-Cookie: AWSELB=6513754B1C5CC94C36D4FA97FE6911DC2DDBF7E465F080A728F3B5B668C02DDFEF36CD5A71C27E7A01616814D2D5248271BDE8AF0B06B7ECAAD740E2288EEE78DA66F8C697;PATH=/;MAX-AGE=600 X-Powered-By: ASP.NET Content-Length: 156 Connection: keep-alive HTTP/2 200 cache-control: private content-type: text/html; charset=utf-8 server: Microsoft-IIS/10.0 set-cookie: ASP.NET_SessionId=egj0k21yj2p3jueslsa3dni5; path=/; secure; HttpOnly x-aspnet-version: 4.0.30319 x-powered-by: ASP.NET date: Thu, 06 Aug 2020 12:43:16 GMT content-length: 39470 |
Not Available |